Menu
For many companies the R&D pipeline contains ‘the future of the company’ as it is the main and often the only, source of future products.
Pharmaceutical R&D is a complex, long and expensive task with a high project attrition rate. Only 5% of drug projects, that reach the stage of
A good understanding of the R&D pipeline and portfolio is essential to reduce waste, duplication and poor use of valuable resources, says Joe de Sousa
Have your say / Follow us
R&D Today is the outreach site for the Research and Development Management Association, a charitable organisation that supports research, best practice and innovation. www.radma.net
© Copyright R&D Today
All rights reserved.